Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
ADMA Biologics Inc
ADMACurrent price
13.16 USD
-0.11 USD (-0.83%)
Last closed
13.58 USD
Company
www.admabiologics.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
3 187 373 568 USD
Yield for 12 month
+237.44 %
1Y
3Y
5Y
10Y
15Y
ADMA
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey. Address: 465 State Route 17, Ramsey, NJ, United States, 07446
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
13.75 USDP/E ratio
–Dividend Yield
–Current Year
+258 214 999 USD
Last Year
+154 079 692 USD
Current Quarter
+81 875 000 USD
Last Quarter
+73 903 677 USD
Current Year
+88 217 999 USD
Last Year
+35 265 157 USD
Current Quarter
+38 915 000 USD
Last Quarter
+30 898 936 USD
Key Figures ADMA
1 year
3 years
5 years
10 years
EBITDA
55 470 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
8.51 %
PEG Ratio
–
Return On Equity TTM
-2.43 %
Wall Street Target Price
13.75 USD
Revenue TTM
283 176 000 USD
Book Value
0.66 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
43.9 %
Dividend Yield
–
Gross Profit TTM
35 265 157 USD
Earnings per share
-0.02 USD
Diluted Eps TTM
-0.02 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-1.29 %
Dividend Analytics ADMA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ADMA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ADMA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
33.3333
Enterprise Value Revenue
10.4246
Price Sales TTM
10.4618
Enterprise Value EBITDA
105.2591
Price Book MRQ
18.5802
Financials ADMA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ADMA
For 52 weeks
3.06 USD
13.95 USD
50 Day MA
10.58 USD
Shares Short Prior Month
9 440 492
200 Day MA
6.32 USD
Short Ratio
2.2
Shares Short
7 268 371
Short Percent
3.23 %
BeatStart